Hip Arthroplasty with Logica Mirror Femoral Stem

Launched by LIMACORPORATE S.P.A · Aug 5, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at the Logica Mirror femoral stem, a device used in hip replacement surgeries. The main goal is to gather more information about how well this implant works and how safe it is after surgery. Researchers will closely monitor patients over three years, checking their recovery progress through medical scores, X-rays, and any side effects they may experience.

To be part of this trial, patients need to be between 65 and 74 years old and have had either a partial or total hip replacement using the Logica Mirror stem at Nemocnice Kyjov Hospital between January 2010 and December 2021. Participants should be willing to undergo follow-up evaluations to track their recovery. It's important to note that younger individuals under 18, as well as pregnant or nursing women, are not eligible to join. If you qualify, you can expect regular check-ins to assess how the implant is performing and to ensure your recovery is on track.

Gender

ALL

Eligibility criteria

• • All patients that underwent partial or total hip arthroplasty and implanted with LOGICA MIRROR femoral stem between Jan 2010 and Dec 2021 at Nemocnice Kyjov Hospital (CZ) in accordance with the indication for use of the product and site standard of practice.
• Additional Inclusion criteria:
• • Availability of patients' immediate post-operative radiograph (baseline) and of a number of follow-up x-rays that the Principal Investigator deems sufficient for an effective radiographic implant evaluation and stability assessment;
• • Patient is willing and able to complete additional follow-up evaluations if needed after signing ICF.
• • Exclusion criteria
• • Age \< 18 years;
• • Female patients who are pregnant, nursing, or planning a pregnancy